Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Echocardiography. 2016 Sep;33(9):1344–1352. doi: 10.1111/echo.13281

TABLE 3.

Comparison of CMR parameters in individuals with and without cardiac sarcoidosis or its associated myocardial damage (CS+ and CS− groups)

Total
population
N=62		 LGE −
N=31		 LGE +
N=31		 P-value
LGE burden
  (%)		 4.2±7.5   0±0 8.4±8.7 <.00001
LV EDVi
  (mL/m2)		  72±16 74±18  70±14   .35
LV ESVi
  (mL/m2)		  29±9 30±11  28±7   .52
LV EF
  (%)		  60±6 60±7  60±4   .65
LV mass
  index
  (g/m2)		  48±13 46±12  50±14   .21
RV EDVi
  (mL/m2)		  78±18 78±18  78±19   .87
RV ESVi
  (mL/m2)		  38±14 36±11  40±16   .20
RV EF
  (%)		  52±8 54±6  50±9   .03

LGE, late gadolinium enhancement; LV/RV, left/right ventricular; EF, ejection fraction; EDVi/ESVi, end- diastolic/end- systolic volume index.